Obstetrics & Gynecology · Orange, CA
NPI
1003097692
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
101 the City Dr S, Building 56, Department of OB/GYN
Orange, CA, 92868
Phone (714) 456-8224
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$177K
848 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Laura C Skoczylas prescribed most often to Medicare patients was Estradiol, with 330 prescriptions and refills. In total Laura C Skoczylas wrote 848 Medicare prescriptions that cost $177K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 330 | 1,145 | 170 | $16K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 65 | 65 | 45 | $688 |
| Myrbetriq Mirabegron | 62 | 157 | 29 | $73K |
| Estring Estradiol | 54 | 159 | 19 | $33K |
| Gemtesa Vibegron | 43 | 56 | 13 | $29K |
| Cephalexin Generic | 40 | 48 | 31 | $397 |
| Mirabegron Er Mirabegron | 33 | 82 | 26 | $16K |
| Yuvafem Estradiol | 28 | 69 | 11 | $2,765 |
| Methenamine Hippurate Generic | 26 | 74 | Under 11 | $2,328 |
| Fluconazole Generic | 26 | 26 | 20 | $159 |
| Ibuprofen Generic | 18 | 18 | 17 | $168 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 18 | 31 | Under 11 | $276 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | Under 11 | $64.07 |
| Vandazole Metronidazole | 11 | 11 | Under 11 | $601 |
| Estrace Estradiol | 11 | 36 | Under 11 | $605 |
Brand drugs: 175 claims; generic drugs: 673 claims; opioid claims: 17.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Laura C Skoczylas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.